CTI Makes Over Zevalin As Front-Line NHL Therapy Booster
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug is on FDA fast track and new partner is on board, but firm must still clear roadblocks to win acceptance in the marketplace.